Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity is a research paper published in Value in Health (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Human Genome Research Institute
Grant: R01 HG011792
Canada Research Chairs
National Institutes of Health
FWCI
9.02
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords